Results 301 to 310 of about 4,684,794 (400)

Administration Studies in Equine Antidoping Research: Designing Scientific Investigations to Effectively Direct Medication Control in Racehorses

Drug Testing and Analysis, EarlyView.
ABSTRACT Pharmacokinetics is the study of the movement of drug in the body and includes the processes of absorption, distribution, metabolism, and excretion. Pharmacodynamics is the pharmacologic effect of the drug on the body. The pharmacokinetics of a drug determines its pharmacologic effect. Pharmacokinetic studies describe drug concentrations while
Heather K. Knych
wiley   +1 more source

Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients. [PDF]

Biomedicines
Dinoi G, Togo MV, Guida P, Deruvo C, Samarelli F, Imbrici P, Nicolotti O, De Luca A, Mastroianni F, Liantonio A, Altomare CD.   +10 more
europepmc   +1 more source

Optimal Treatment of Non-traumatic Intracerebral Hemorrhage Associated with Anticoagulant Therapy

, 2000
Mikihiko Takeshita, Takakazu Kawamata, Toshiyuki Sasaki, Masahiro Izawa, Tomokatsu Hori   +4 more
openalex   +2 more sources

Remolding Waste Liquid From the Zeolite Synthesis Process Into Wrinkled Dressings for Diabetic Wound Therapeutics With Immunomodulation

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Waste liquid from natural clay‐to‐zeolite synthesis is remolded into a metal‐wrinkled dressing showing outstanding hemostatic, antibacterial, and wound‐healing effects. Chronic wounds resulting from diabetes are among the most common complications in diabetic patients.
Hanlin Yao, Xinyu You, Songqi Wu, Yunhao Wang, Di Hu, Yongsheng Ma, Jun Luo, Jie Qiu, Lihua Zhou   +8 more
wiley   +1 more source

LOLATAO-An Artificial-Intelligence-Based Virtual Assistant for Clinical Follow-Up of Patients with Non-Valvular Atrial Fibrillation (AF) Undergoing Oral Anticoagulant Therapy (OAT): A Feasibility Study. [PDF]

J Clin Med
Santamaría A, Antón-Maldonado C, Sánchez-Quiñones B, Ibarra Vega N, González P, Carrasco R.   +5 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Recurrent Acute Myocardial Infarction in a Patient with Severe Coronary Artery Ectasia Followed Up for 10 Years: Implications of Anticoagulant Therapy. [PDF]

Am J Case Rep
Liang M, Sun P, Li Y.
europepmc   +1 more source

Recurrence of Idiopathic Thromboembolism During Anticoagulant Therapy

, 2001
Kojiro Tanimoto, Katsufumi Mizushige, Kazushi Yukiiri, Takashi Ueda, Yoshihiro Wada, Koji Ohmori, Masakazu Kohno   +6 more
openalex   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source